13
Jun
Jun
In a current research revealed in Communications Biology, researchers evaluated the therapeutic efficacy of Navoximod, mixed with herpes simplex 1 (HSV-1) virotherapy, in opposition to hepatocellular carcinoma (HCC). Research: Navoximod modulates native HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy by way of an injectable hydrogel. Picture Credit score: PaeGAG/Shutterstock.com Background Most cancers immunotherapy has […]